| Literature DB >> 36212954 |
Shaona Xu1, Yanan Yu1, Hongling Liu2, Weiwei Qiu3, Yu Tang4, Ying Liu1.
Abstract
Objective: To explore the application effect of nursing outcome-oriented integrated zero-defect nursing combined with respiratory function training in long-term bedridden patients with stroke.Entities:
Year: 2022 PMID: 36212954 PMCID: PMC9546674 DOI: 10.1155/2022/4425680
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.650
Comparison of Rosenbek aspiration degree classification among the three groups before treatment [case (%)].
| Group | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
|---|---|---|---|---|---|---|---|---|
| Group A ( | 4 (10.00) | 6 (15.00) | 5 (12.50) | 6 (15.00) | 4 (10.00) | 5 (12.50) | 4 (10.00) | 6 (15.00) |
| Group B ( | 3 (7.50) | 5 (12.50) | 6 (15.00) | 7 (17.50) | 5 (12.50) | 5 (12.50) | 5 (12.50) | 4 (10.00) |
| Group C ( | 4 (10.00) | 5 (12.50) | 5 (12.50) | 5 (12.50) | 6 (15.00) | 6 (15.00) | 4 (10.00) | 5 (12.50) |
| z value | 0.018 | |||||||
|
| 0.991 | |||||||
Note. b indicated P < 0.05 when compared with group B; c indicated P < 0.05 with group C.
Comparison of Rosenbek aspiration degree classification among the three groups after treatment [case (%)].
| Group | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
|---|---|---|---|---|---|---|---|---|
| Group A ( | 10 (25.00)c | 10 (25.00)c | 9 (22.50)c | 6 (15.00)c | 2 (5.00)c | 1 (2.50)c | 1 (2.50)c | 1 (2.50)c |
| Group B ( | 9 (22.50)c | 9 (22.50)c | 8 (20.00)c | 5 (12.50)c | 4 (10.00)c | 3 (7.50)c | 2 (5.00)c | 1 (2.50)c |
| Group C ( | 5 (12.50) | 5 (12.50) | 5 (12.50) | 5 (12.50) | 7 (17.50) | 7 (17.50) | 3 (7.50) | 3 (7.50) |
|
| 11.175 | |||||||
|
| 0.004 | |||||||
Note. b indicated P < 0.05 when compared with group B; c indicated P < 0.05 with group C.
Comparison of respiratory function among the three groups (‾x ± s).
| Group | Oxygen saturation (%) | Arterial partial pressure (mmHg) | Respiratory function (cm H2O) | |||
|---|---|---|---|---|---|---|
| Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | |
| Group A ( | 89.94 ± 2.36 | 98.32 ± 2.10abc | 87.77 ± 2.26 | 98.69 ± 1.89abc | 26.93 ± 1.45 | 18.58 ± 1.37abc |
| Group B ( | 90.85 ± 2.04 | 95.70 ± 2.84ac | 87.63 ± 1.28 | 93.75 ± 1.43ac | 26.62 ± 1.55 | 23.71 ± 2.45a |
| Group C ( | 90.87 ± 2.43 | 92.57 ± 1.74a | 86.81 ± 1.98 | 91.59 ± 1.65a | 26.73 ± 1.84 | 24.68 ± 2.08a |
|
| 2.157 | 64.113 | 3.017 | 190.423 | 0.382 | 105.857 |
|
| 0.120 | <0.001 | 0.053 | <0.001 | 0.683 | <0.001 |
Note.an indicated P < 0.05 when compared with the same group before intervention; b indicated P < 0.05 when compared with group B; c indicated P < 0.05 when compared with group C.
Comparison of swallowing function among the three groups [cases (%)].
| Group | Cure | Markedly effective | Effective | Ineffective | Total effective rate |
|---|---|---|---|---|---|
| Group A ( | 13 (32.50) | 21 (52.50) | 4 (10.00) | 2 (5.00) | 34 (85.00)c |
| Group B ( | 10 (25.00) | 18 (45.00) | 5 (12.50) | 7 (17.50) | 28 (70.00)c |
| Group C ( | 6 (15.00) | 8 (20.00) | 15 (37.50) | 11 (27.50) | 14 (35.00) |
|
| 22.679 | ||||
|
| <0.001 |
Note. b indicated P < 0.05 when compared with group B; c indicated P < 0.05 with group C.
Comparison of the incidence of complications among the three groups [cases (%)].
| Group | DVT | Pulmonary infection | Aspiration | Total complication rate |
|---|---|---|---|---|
| Group A ( | 1 (2.50) | 4 (10.00) | 1 (2.50) | 6 (15.00)bc |
| Group B ( | 3 (7.50) | 9 (22.50) | 2 (5.00) | 14 (35.00)c |
| Group C ( | 10 (25.00) | 15 (37.50) | 12 (30.00) | 37 (92.50) |
|
| 51.930 | |||
|
| <0.001 |
Note. b indicated P < 0.05 when compared with group B; c indicated P < 0.05 with group C.
Comparison of quality of life among the three groups (‾x ± s).
| Group | Physical function | Psychological function | Social function | Material life status | ||||
|---|---|---|---|---|---|---|---|---|
| Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | |
| Group A ( | 42.50 ± 8.91 | 45.13 ± 4.99 | 31.25 ± 6.00 | 65.03 ± 7.60abc | 34.25 ± 6.74 | 71.38 ± 6.17abc | 22.23 ± 4.12 | 45.28 ± 3.97abc |
| Group B ( | 42.90 ± 4.49 | 44.68 ± 4.48 | 32.33 ± 4.52 | 59.58 ± 5.91ac | 33.58 ± 5.27 | 65.85 ± 6.44ac | 22.13 ± 3.27 | 38.20 ± 3.83ac |
| Group C ( | 40.00 ± 6.84 | 44.63 ± 5.16a | 32.20 ± 3.65 | 53.78 ± 6.41a | 33.18 ± 6.41 | 60.83 ± 6.16a | 21.48 ± 2.04 | 29.80 ± 3.29a |
|
| 2.026 | 0.127 | 0.594 | 28.389 | 0.310 | 28.478 | 0.626 | 174.587 |
|
| 0.136 | 0.881 | 0.554 | <0.001 | 0.734 | <0.001 | 0.536 | <0.001 |
Note.an indicated P < 0.05 when compared with the same group before intervention; b indicated P < 0.05 when compared with group B; c indicated P < 0.05 when compared with group C.